Genmab A/S ADS (GMAB) Financials
Key financial figures for Genmab A/S ADS (Q2 2026).
Genmab A/S reported revenue of $1.16 billion for Q2 FY2026, up 24.9% from the same period a year earlier. Net income was $303.0 million, or $0.49 per share. Operating margin came to 35.24%, against 38.92% a year earlier. Free cash flow for the period was $48.0 million. Across the last 5 reported quarters, quarterly revenue has risen from $924.8 million in Q2 FY2025 to $1.16 billion in Q2 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Genmab A/S are on the SentiSense financials page.
- Revenue
- $1.2B
- Net Income
- $303M
- EPS
- $0.49
- Total Assets
- $12.5B
- Operating Cash Flow
- $51M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $1.2B | $303M | $0.49 | 35.24% | $48M |
| Q1 FY2026 | $899M | $53M | $0.08 | 25.11% | -$2M |
| Q4 FY2025 | $1.1B | $31M | $0.05 | 22.97% | $287M |
| Q3 FY2025 | $1.0B | $401M | $0.65 | 44.91% | $534M |
| Q2 FY2025 | $925M | $336M | $0.54 | 38.92% | $52M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $3.7B | $964M | $1.54 | 33.6% | $1.1B |
| FY2024 | $21.5B | $7.8B | $12.14 | 31.14% | $7.6B |
| FY2023 | $16.5B | $4.4B | $6.60 | 32.3% | $7.0B |
Frequently asked questions
What was Genmab A/S's revenue last quarter?
Genmab A/S reported revenue of $1.16 billion for Q2 FY2026, up 24.9% from the same period a year earlier.
Is Genmab A/S profitable?
Yes. Genmab A/S reported net income of $303.0 million for Q2 FY2026, a net margin of 26.23% on revenue.
How has Genmab A/S's margin trended?
Operating margin was 35.24% in Q2 FY2026, compared with 38.92% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Genmab A/S generate?
Genmab A/S generated free cash flow of $48.0 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Genmab A/S ADS on SentiSense, with up to forty quarters and twenty fiscal years of history.